Safety and efficacy of alfuzosin 10 mg once‐daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double‐blind, placebo‐controlled studies
Open Access
- 23 July 2003
- journal article
- clinical trial
- Published by Wiley in BJU International
- Vol. 92 (3) , 257-261
- https://doi.org/10.1046/j.1464-410x.2003.04309.x
Abstract
OBJECTIVES To examine the efficacy and safety of a once‐daily formulation of alfuzosin in a pooled analysis of three parallel, randomized, double‐blind, placebo‐controlled 3‐month studies of patient...Keywords
This publication has 19 references indexed in Scilit:
- AlfuzosinDrugs, 2002
- Efficacy and Safety of a New Prolonged Release Formulation of Alfuzosin 10 mg Once Daily versus Alfuzosin 2.5 mg Thrice Daily and Placebo in Patients with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2000
- A Meta-Analysis on the Efficacy and Tolerability of α1-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic ObstructionEuropean Urology, 1999
- Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General PracticeProstate Cancer and Prostatic Diseases, 1998
- Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III TrialUrology, 1998
- Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic HyperplasiaUrology, 1998
- Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1998
- Quantification and distribution of α1‐adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portionsBritish Journal of Pharmacology, 1997
- Urinary Flow Rates in Patients with Benign Prostatic Hypertrophy following Treatment with AlfuzosinBritish Journal of Urology, 1992
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991